Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of the fiscal period ended Tuesday, March 31, 2026.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2026 (2026-03-31): 10.53%.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-12.00%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-125.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-72.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-101.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-82.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-77.92%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Agenus Inc.
Market Cap
$311.90M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-12.00%
3Y Avg
-125.79%
5Y Avg
-72.86%
Market Cap
$309.19M
Return on Invested Capital (ROIC)
-28.88%
TTM Avg
-35.80%
3Y Avg
-1011.32%
5Y Avg
-772.02%
Market Cap
$318.43M
Return on Invested Capital (ROIC)
-35.92%
TTM Avg
-35.67%
3Y Avg
-36.59%
5Y Avg
-30.23%
Market Cap
$321.76M
Return on Invested Capital (ROIC)
18.15%
TTM Avg
3.75%
3Y Avg
-6.35%
5Y Avg
-21.63%
Market Cap
$322.71M
Return on Invested Capital (ROIC)
-136.92%
TTM Avg
-105.47%
3Y Avg
-71.42%
5Y Avg
-55.10%
Market Cap
$324.76M
Return on Invested Capital (ROIC)
-164.32%
TTM Avg
-159.25%
3Y Avg
-125.06%
5Y Avg
-125.06%
Market Cap
$329.37M
Return on Invested Capital (ROIC)
-85.56%
TTM Avg
-114.55%
3Y Avg
-77.72%
5Y Avg
-63.50%
Market Cap
$330.19M
Return on Invested Capital (ROIC)
-40.51%
TTM Avg
-48.13%
3Y Avg
-48.38%
5Y Avg
-39.85%
Market Cap
$293.30M
Return on Invested Capital (ROIC)
-129.90%
TTM Avg
-509.42%
3Y Avg
-303.54%
5Y Avg
-247.13%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Agenus Inc. (AGEN) | $311.90M | N/A | -12.00% | -125.79% | -72.86% |
| Benitec Biopharma Inc. (BNTC)vs › | $309.19M | -28.88% | -35.80% | -1011.32% | -772.02% |
| C4 Therapeutics, Inc. (CCCC)vs › | $318.43M | -35.92% | -35.67% | -36.59% | -30.23% |
| Sanara MedTech Inc. (SMTI)vs › | $321.76M | 18.15% | 3.75% | -6.35% | -21.63% |
| Avita Medical Inc. (RCEL)vs › | $322.71M | -136.92% | -105.47% | -71.42% | -55.10% |
| CapsoVision, Inc. (CV)vs › | $324.76M | -164.32% | -159.25% | -125.06% | -125.06% |
| Cabaletta Bio, Inc. (CABA)vs › | $329.37M | -85.56% | -114.55% | -77.72% | -63.50% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $330.19M | -40.51% | -48.13% | -48.38% | -39.85% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $293.30M | -129.90% | -509.42% | -303.54% | -247.13% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $292.59M | -122.21% | -122.21% | -122.21% | -122.21% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-03-31 | 10.53% |
| 2025-12-31 | -34.52% |
| 2024-09-30 | -65.54% |
| 2024-06-30 | -323.01% |
| 2024-03-31 | -85.63% |
| 2023-12-31 | -274.32% |
| 2023-09-30 | -154.98% |
| 2023-06-30 | -115.69% |
| 2023-03-31 | -88.94% |
| 2022-12-31 | -79.68% |
| 2022-09-30 | -65.22% |
| 2022-06-30 | 17.25% |
| 2022-03-31 | 10.83% |
| 2021-12-31 | 8.31% |
| 2021-09-30 | 20.16% |
| 2021-06-30 | -183.90% |
| 2021-03-31 | -84.42% |
| 2020-12-31 | -137.18% |
| 2020-09-30 | -195.34% |
| 2020-06-30 | -257.39% |
| 2020-03-31 | -232.03% |
| 2019-12-31 | -207.68% |
| 2019-09-30 | -162.08% |
| 2019-06-30 | -81.54% |
| 2019-03-31 | -36.29% |
| 2018-12-31 | -180.80% |
| 2018-09-30 | -157.93% |
| 2018-06-30 | -148.55% |
| 2018-03-31 | -131.24% |
| 2017-12-31 | -101.17% |
| 2017-09-30 | -81.42% |
| 2017-06-30 | -68.22% |
| 2017-03-31 | -55.53% |
| 2016-12-31 | -92.43% |
| 2016-09-30 | -75.60% |
| 2016-06-30 | -49.40% |
| 2016-03-31 | -47.56% |
| 2015-12-31 | -37.81% |
| 2015-09-30 | -37.40% |
| 2015-06-30 | -49.58% |
| 2015-03-31 | -53.59% |
| 2014-12-31 | -65.17% |
| 2014-09-30 | -40.57% |
| 2014-06-30 | -34.91% |
| 2014-03-31 | -30.81% |
| 2013-12-31 | -89.03% |
| 2013-09-30 | -73.48% |
| 2013-06-30 | -124.53% |
| 2013-03-31 | -76.18% |
| 2012-12-31 | -22.41% |
| 2012-06-30 | -25.38% |
| 2012-03-31 | -22.45% |
| 2011-12-31 | -125.15% |
| 2011-09-30 | -102.25% |
| 2011-06-30 | -111.36% |
| 2011-03-31 | -92.95% |
| 2010-12-31 | -84.85% |
| 2010-09-30 | -75.85% |
| 2010-06-30 | -62.75% |
| 2010-03-31 | -72.68% |
| 2009-12-31 | -62.48% |
| 2009-09-30 | -64.77% |
| 2009-06-30 | -98.89% |
| 2009-03-31 | -87.95% |
| 2008-12-31 | -75.55% |
| 2008-09-30 | -69.92% |
| 2008-06-30 | -58.74% |
| 2008-03-31 | -67.67% |
| 2007-12-31 | -91.67% |
| 2007-09-30 | -85.03% |
| 2007-06-30 | -81.08% |
| 2007-03-31 | -77.52% |
| 2006-12-31 | -79.06% |
| 2006-09-30 | -116.52% |
| 2006-06-30 | -111.54% |
| 2006-03-31 | -98.79% |
| 2005-12-31 | -82.93% |
| 2005-09-30 | -37.20% |
| 2005-06-30 | -59.00% |
| 2005-03-31 | -47.43% |
| 2004-12-31 | -59.26% |
| 2004-09-30 | -52.24% |
| 2004-06-30 | -46.04% |
| 2004-03-31 | -44.93% |
| 2003-12-31 | -54.80% |
| 2003-09-30 | -48.23% |
| 2003-06-30 | -55.84% |
